WuXi PharmaTech (Cayman) Inc. Income (Loss) from Continuing Operations, Per Basic Share
WuXi PharmaTech (Cayman) Inc. reported Income (Loss) from Continuing Operations, Per Basic Share of $0.15 per share for the 12-month period ending 2012-12-31, per its 20-F filed 2013-04-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2013-04-17
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|
| 2012-12-31 | $0.15 20-F · filed 2013-04-17 |
| 2011-12-31 | $0.14 20-F · filed 2013-04-17 |
| 2010-12-31 | $0.16 20-F · filed 2013-04-17 |
| 2009-12-31 | $0.10 20-F · filed 2012-04-20 |
| 2008-12-31 | -$0.03 20-F · filed 2011-04-27 |